| Ambroxol in the 21st century: pharmacological and clinical update M Malerba, B Ragnoli Expert opinion on drug metabolism & toxicology 4 (8), 1119-1129, 2008 | 353 | 2008 |
| Feasibility and clinical impact of out-of-ICU noninvasive respiratory support in patients with COVID-19-related pneumonia C Franco, N Facciolongo, R Tonelli, R Dongilli, A Vianello, L Pisani, ... European Respiratory Journal 56 (5), 2020 | 273 | 2020 |
| Reference values for exhaled nitric oxide (reveno) study M Olivieri, G Talamini, M Corradi, L Perbellini, A Mutti, C Tantucci, ... Respiratory research 7, 1-6, 2006 | 212 | 2006 |
| Plasma homocysteine and folate levels in patients with chronic plaque psoriasis M Malerba, P Gisondi, A Radaeli, R Sala, PG Calzavara Pinton, ... British Journal of Dermatology 155 (6), 1165-1169, 2006 | 200 | 2006 |
| High serum levels of tumour necrosis factor‐α and interleukin‐8 in severe asthma: markers of systemic inflammation? M Silvestri, M Bontempelli, M Giacomelli, M Malerba, GA Rossi, ... Clinical & Experimental Allergy 36 (11), 1373-1381, 2006 | 193 | 2006 |
| COVID-19 and obesity: dangerous liaisons G Caci, A Albini, M Malerba, DM Noonan, P Pochetti, R Polosa Journal of clinical medicine 9 (8), 2511, 2020 | 183 | 2020 |
| Identification of IL-17F/frequent exacerbator endotype in asthma FLM Ricciardolo, V Sorbello, A Folino, F Gallo, GM Massaglia, G Favatà, ... Journal of Allergy and Clinical Immunology 140 (2), 395-406, 2017 | 148 | 2017 |
| Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults B Balbi, P Pignatti, M Corradi, P Baiardi, L Bianchi, G Brunetti, A Radaeli, ... European Respiratory Journal 30 (4), 769-781, 2007 | 138 | 2007 |
| Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients M Bellan, G Patti, E Hayden, D Azzolina, M Pirisi, A Acquaviva, ... Scientific reports 10 (1), 20731, 2020 | 129 | 2020 |
| Effect of twelve-months therapy with oral ambroxol in preventing exacerbations in patients with COPD. Double-blind, randomized, multicenter, placebo-controlled study (the … M Malerba, A Ponticiello, A Radaeli, G Bensi, V Grassi Pulmonary pharmacology & therapeutics 17 (1), 27-34, 2004 | 126 | 2004 |
| Exhaled nitric oxide as a biomarker in COPD and related comorbidities M Malerba, A Radaeli, A Olivini, G Damiani, B Ragnoli, P Montuschi, ... BioMed research international 2014, 2014 | 111 | 2014 |
| Folic acid in general medicine and dermatology P Gisondi, F Fantuzzi, M Malerba, G Girolomoni Journal of dermatological treatment 18 (3), 138-146, 2007 | 102 | 2007 |
| COPD and the metabolic syndrome: an intriguing association E Clini, E Crisafulli, A Radaeli, M Malerba Internal and emergency medicine 8, 283-289, 2013 | 95 | 2013 |
| Effect of acute exacerbations on circulating endothelial, clotting and fibrinolytic markers in COPD patients R Polosa, M Malerba, RR Cacciola, JB Morjaria, C Maugeri, G Prosperini, ... Internal and emergency medicine 8, 567-574, 2013 | 89 | 2013 |
| Neutrophilic inflammation and IL-8 levels in induced sputum of alpha-1-antitrypsin PiMZ subjects M Malerba, F Ricciardolo, A Radaeli, C Torregiani, L Ceriani, E Mori, ... Thorax 61 (2), 129-133, 2006 | 87 | 2006 |
| Non-invasive biomarkers of lung inflammation in smoking subjects M Malerba, P Montuschi Current medicinal chemistry 19 (2), 187-196, 2012 | 82 | 2012 |
| Pharmacological treatment of chronic obstructive pulmonary disease: from evidence-based medicine to phenotyping P Montuschi, M Malerba, G Santini, M Miravitlles Drug discovery today 19 (12), 1928-1935, 2014 | 78 | 2014 |
| Acute exacerbation of idiopathic pulmonary fibrosis: lessons learned from acute respiratory distress syndrome? A Marchioni, R Tonelli, L Ball, R Fantini, I Castaniere, S Cerri, F Luppi, ... Critical care 22, 1-13, 2018 | 76 | 2018 |
| Usefulness of exhaled nitric oxide and sputum eosinophils in the long-term control of eosinophilic asthma M Malerba, B Ragnoli, A Radaeli, C Tantucci Chest 134 (4), 733-739, 2008 | 76 | 2008 |
| Outcomes of COVID-19 patients treated with continuous positive airway pressure outside the intensive care unit R Vaschetto, F Barone-Adesi, F Racca, C Pissaia, C Maestrone, ... ERJ Open Research 7 (1), 2021 | 69 | 2021 |
